TRIO - Translational Research in Oncology
Research-Services
Website
Company Tagline
Advancing cancer research. Life-changing results.
Industry Category
Business Keywords
Company Description
TRIO - Translational Research in Oncology is a leading oncology clinical research organization (CRO) dedicated to accelerating drug development through its robust worldwide network. With decades of experience conducting oncology trials from inception to completion, TRIO - Translational Research in Oncology focuses on pioneering research and science to guide the development of innovative and biologically sound therapies. The translational research model ensures that targeted concepts are brought into clinics on the most rational development path, saving lives with focus and care.
TRIO - Translational Research in Oncology is committed to delivering exceptional research services in oncology. TRIO - Translational Research in Oncology leverages a strong network of investigators, academic leaders, and patient advocates, ensuring the most efficient and effective pathways for drug development. TRIO - Translational Research in Oncology has locations, including its primary address at Suite 1100, 9925-109 Street, Edmonton, Alberta T5K 2J8, CA; Biopark, 11, rue Watt, Paris, 75013, FR; and 1248 Office 360, WTC 3, Montevideo, 11300, UY.
TRIO - Translational Research in Oncology continues to set the standard in oncology clinical research, providing unparalleled expertise and dedication to advancing cancer treatment. TRIO - Translational Research in Oncology remains at the forefront of translational research, pushing the boundaries of what's possible in oncology. We invite the manager of TRIO - Translational Research in Oncology to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and commercial opportunities.
TRIO - Translational Research in Oncology est une organisation de recherche clinique (ORC) de premier plan en oncologie, dédiée à l'accélération du développement de médicaments grâce à son solide réseau mondial. Fort de décennies d'expérience dans la conduite d'essais oncologiques du début à la fin, TRIO - Translational Research in Oncology se concentre sur la recherche et la science pionnières pour guider le développement de thérapies innovantes et biologiquement solides. Le modèle de recherche translationnelle garantit que les concepts ciblés sont introduits dans les cliniques sur le chemin de développement le plus rationnel, sauvant des vies avec concentration et attention.
TRIO - Translational Research in Oncology s'engage à fournir des services de recherche exceptionnels en oncologie. TRIO - Translational Research in Oncology s'appuie sur un solide réseau d'investigateurs, de leaders universitaires et de défenseurs des patients, garantissant ainsi les voies les plus efficaces pour le développement de médicaments. TRIO - Translational Research in Oncology possède des sites, notamment son adresse principale au Suite 1100, 9925-109 Street, Edmonton, Alberta T5K 2J8, CA ; Biopark, 11, rue Watt, Paris, 75013, FR ; et 1248 Office 360, WTC 3, Montevideo, 11300, UY.
TRIO - Translational Research in Oncology continue d'établir la norme en matière de recherche clinique en oncologie, en fournissant une expertise et un dévouement inégalés pour faire progresser le traitement du cancer. TRIO - Translational Research in Oncology reste à l'avant-garde de la recherche translationnelle, repoussant les limites du possible en oncologie. Nous invitons le directeur de TRIO - Translational Research in Oncology à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer davantage votre visibilité et vos opportunités commerciales.
Key Personnel / Employees
Compare Companies Side by Side
Compare TRIO - Translational Research in Oncology with 2 companies in Research-Services
| Comparison Field |
TRIO - Translational Rese...Main Company |
Helix Biogen Institu...View Profile |
NHMRC Clinical Trial...View Profile |
|---|---|---|---|
|
Founded Year
|
— | 2019 | 1988 |
|
Company Size
|
— | 11-50 | 51-200 |
|
City
|
Edmonton, Alberta | Ogbomoso, Oyo State | Sydney, NSW |
|
Country
|
Canada | Nigeria | Australia |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Oncology Clinical Research
Drug Development
Translational Research
Clinical Trials
Cancer Research
CRO Services
Pharmaceutical Research
II & III)
Clinical Trials (Phase I
Oncology
|
12 Total
12 Unique
Unique Skills:
Bioinformatics
Capacity Building
Data Science
Genomics
Immunoinformatic
Laboratory Space
+6
|
11 Total
11 Unique
Unique Skills:
ANZCTR
Biostatistics
Cardiovascular
Diabetes
Genomics
Health Economics
+5
|
3
Total Companies1988
Oldest Founded3
Countries32
Unique SkillsSimilar Companies
Other organizations in the same industry
Western Fire & Forest Resilience Collaborative
Research-ServicesResearch and engagement for actionable fire science and decision making.
Clinical Research Solutions
Research-ServicesSupporting Healthcare Companies with their Clinical Evidence Generation needs
Jarumi Ventures Africa
Research-ServicesBuilding you up the right way.
Alternative Company Names
This company is also known as